Month: April 2026

PRESS RELEASE Courbevoie, France – April 22, 2026 A steady organic revenue growth in the first quarter 2026; An evolving macro-environment and a transitioning portfolio mix; Updated 2026 outlook Q1 2026 Key figures1Revenue of EUR 1,547.0 million, up 4.5% organically, and down 0.8% year-on-year Strong organic growth from Marine & Offshore at +11.2% and Buildings & Infrastructure at +7.3% with moderate growth for Consumer Products Services at +4.3%, Certification at +2.3%, Agri-Food & Commodities at +2.1%, and Industry at +0.7%, Stable scope effect of (0.1)%, from bolt-on acquisitions (+1.8% contribution), net of disposals (-1.9%), Negative currency impact of 5.2%, resulting from the euro’s appreciation against most currencies.Q1 2026 HighlightsMaintained steady performance across most regions, in an environment marked...

Switzerland,  22nd April 2026Trifork Group AG Press Release Announcement: Trifork North America Appoints Patrick Lamb as Chief Executive Officer Patrick Lamb has been appointed Chief Executive Officer of Trifork North America. He brings to the role direct operational experience as the company’s Head of Sales for North America leading the company’s commercial growth across the region, with a track record spanning customer acquisition, strategic  partnerships, and delivery excellence. “Patrick has been deeply involved in our North American business—across customers, partnerships, and execution. He understands where we are strong, where we need to improve, and what it takes to grow in this market. That makes him the right person to lead the next phase.” Says Jørn Larsen, Founder and CEO of Trifork. The appointment reflects Trifork’s...

Sanofi’s Tzield approved in the US to delay the onset of stage 3 type 1 diabetes in young childrenExpanded approval includes children aged one year and above with stage 2 T1D to delay the onset of stage 3 Tzield is the first disease-modifying therapy for children aged one year and above diagnosed with stage 2 T1DParis, April 22, 2026. The US Food and Drug Administration (FDA) has approved the supplemental biologic license application for Tzield (teplizumab-mzwv), expanding the indication from eight years and older to as young as one year of age to delay the onset of stage 3 type 1 diabetes (T1D) in patients diagnosed with stage 2 T1D. The approval was granted under a priority review process and is supported by one-year data from the PETITE-T1D phase 4 study (clinical study identifier: NCT05757713), evaluating safety and pharmacokinetics...

Collaboration combines Lufthansa Technik’s engine services expertise with Woodward’s leading technology to ensure efficiency and increase uptime for CFM LEAP engine-powered aircraft FORT COLLINS, Colo., April 22, 2026 (GLOBE NEWSWIRE) — Woodward, Inc. (NASDAQ: WWD) and Lufthansa Technik have entered an Elite Licensed Repair Service Facility Agreement (LRSF), reinforcing their long-standing cooperation for support of Woodward components on the CFM International LEAP-1A and LEAP-1B* engines. As part of Woodward’s newly established two-tier global support network, Lufthansa Technik is the first network partner authorized to provide the complete range of repair and overhaul services on Woodward fuel controls, valves, and actuators on the CFM LEAP engines. For operators of Airbus A320neo and Boeing 737 MAX aircraft, this agreement will...

SOUTH SAN FRANCISCO, Calif., April 22, 2026 (GLOBE NEWSWIRE) — Maze Therapeutics, Inc. (Nasdaq: MAZE) today announced the pricing of its underwritten registered offering of 5,540,000 shares of its common stock at a price of $23.50 per share. In addition, and in lieu of common stock, Maze is offering to certain investors pre-funded warrants to purchase up to an aggregate of 850,000 shares of common stock at a purchase price of $23.499 per pre-funded warrant, which represents the per share price for the common stock less the $0.001 per share exercise price for each such pre-funded warrant. The gross proceeds to Maze from the offering, before deducting underwriting discounts and commissions and other offering expenses payable by Maze, are expected to be $150 million. The offering is expected to close on or about April 23, 2026, subject...

SHENZHEN, China, April 21, 2026 (GLOBE NEWSWIRE) — On April 17th, Han’s Laser (002008.SZ) released its 2025 annual report. The report indicates that Han’s Laser exceeded annual revenue of USD 2.67 billion, up 27.00% year-on-year, marking a three-year high in revenue scale. Its net profit attributable to shareholders of the listed company was CNY 1.19 billion, while its net profit attributable to shareholders of the listed company excluding non-recurring gains and losses was CNY 810 million, with the latter surging by as much as 82.28% year-on-year, reflecting continuous improvement in its operating quality. Driven by the three major trends of explosive growth in AI computing power, the globalization of new energy, and the domestic substitution of semiconductors, Han’s Laser leverages its vertically integrated technological advantages...

NATIONAL HARBOR, Md., April 21, 2026 (GLOBE NEWSWIRE) — At the U.S. Navy League’s Sea-Air-Space Exposition 2026 today, Kari Wilkinson, HII (NYSE: HII) executive vice president and president of Newport News Shipbuilding, highlighted the company’s commitment to strengthen and expand the U.S. maritime industrial base. Wilkinson served as a panelist for a discussion on advancing strategic requirements with a resilient shipbuilding enterprise. The shipbuilding panel examined the broad initiatives shaping the maritime industrial base and how policy, budgeting, and long term planning can sustain the nation’s maritime dominance. Chris Miller, the U.S. Navy’s portfolio acquisition executive for maritime (PAE Maritime), moderated the discussion. During the panel, Wilkinson highlighted how HII is growing and retaining the workforce needed...